The observational EURACAN prospective clinical registry dedicated to epithelioid hemangioendothelioma: The protocol of an international and collaborative effort on an ultra-rare entity.

Saved in:
Bibliographic Details
Title: The observational EURACAN prospective clinical registry dedicated to epithelioid hemangioendothelioma: The protocol of an international and collaborative effort on an ultra-rare entity.
Authors: Frezza AM; Fondazione IRCCS Istituto Nazionale Tumori, Medical Oncology 2, Milan, Italy., Leonard H; EHE Rare Cancer Charity, London, United Kingdom., Aggerholm-Pedersen N; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark., Badalamenti G; Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy., Baili P; Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale Tumori, Data Science Unit, Milan, Italy., Baldi GG; Department of Oncology, Hospital of Prato, Azienda USL Toscana Centro, Prato, Italy., Bauer S; Medical Oncology, University Hospital Essen, Essen, Germany., Bazzurri S; Department of Oncology, Hospital of Prato, Azienda USL Toscana Centro, Prato, Italy., Benzonelli I; Medical Oncology, Ospedale San Luigi, Orbassano, Italy., Bertuzzi A; Medical Oncology, IRCCS, Humanitas Research Hospital, Rozzano-Milano, Italy., Blay JY; Medical Oncology, Centre Léon Bérard, Lyon, France., Bianchi G; IRCCS Istituto Ortopedico Rizzoli, Clinica Ortopedica e Traumatologica III a Prevalente Indirizzo Oncologico, Bologna, Italy., Bonfarnuzzo S; Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale Tumori, Data Science Unit, Milan, Italy., Bouvier C; Medical Oncology, Centre Léon Bérard, Lyon, France., Boye K; Medical Oncology, Oslo University Hospital, Oslo, Norway., Martin Broto J; Medical Oncology, Fundación Jimenez Diaz University Hospital, Madrid, Spain., Brunello A; Istituto Oncologico Veneto IOV-IRCCS, Medical Oncology 1, Padua, Italy., Campanacci D; Orthopaedic Oncology, Careggi University Hospital, Florence, Italy., Casali PG; Fondazione IRCCS Istituto Nazionale Tumori, Medical Oncology 2, Milan, Italy., Cicala C; Medical Oncology, Hospital Universitari Vall d'Hebron, Spain., Crotti E; Medical Oncology, IRCCS, Humanitas Research Hospital, Rozzano-Milano, Italy., D'Ambrosio L; Medical Oncology, Ospedale San Luigi, Orbassano, Italy., Dei Tos AP; Department of Pathology, Azienda Ospedaliera di Padova, Padua, Italy., Dieckmann N; Medical Oncology, University Hospital Essen, Essen, Germany., Dufresne A; Medical Oncology, Centre Léon Bérard, Lyon, France., Elston S; Sarcoma Unit, The Royal Marsden NHS Foundation Trust, London, United Kingdom., Ferraresi V; Sarcomas and Rare Tumors Departmental Unit-IRCCS Regina Elena National Cancer Institute, Rome, Italy., Gabellini S; Department of Oncology, Hospital of Prato, Azienda USL Toscana Centro, Prato, Italy., Giani C; Fondazione IRCCS Istituto Nazionale Tumori, Medical Oncology 2, Milan, Italy., Giannusa V; Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy., Gil Sanjines M; Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale Tumori, Evaluative Epidemiology Unit, Milan, Italy., Grassani T; Medical Oncology, Università Campus Bio-Medico, Rome, Italy., Gronchi A; Fondazione IRCCS Istituto Nazionale Tumori, Sarcoma Surgery, Milan, Italy., Lasalvia P; Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale Tumori, Evaluative Epidemiology Unit, Milan, Italy., Lindskog S; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Hindi N; Medical Oncology, Fundación Jimenez Diaz University Hospital, Madrid, Spain., Ingrosso M; Fondazione IRCCS Istituto Nazionale Tumori, Medical Oncology 2, Milan, Italy., Ivanescu A; EHE Italia, Milan, Italy., Jones R; Sarcoma Unit, The Royal Marsden NHS Foundation Trust, London, United Kingdom., Lugowska I; Maria Skłodowska Curie Institute-Oncology Centre, Early Phase Trial Unit, Warsaw, Poland., Ketzer J; Medical Oncology, University Hospital Essen, Essen, Germany., Mariuk-Jarema A; Maria Skłodowska Curie Institute-Oncology Centre, Early Phase Trial Unit, Warsaw, Poland., Mazzocca A; Medical Oncology, Università Campus Bio-Medico, Rome, Italy., Monteleone L; Fondazione IRCCS Istituto Nazionale Tumori, Medical Oncology 2, Milan, Italy., Morosi C; Department of Radiology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Napolitano A; Sarcoma Unit, The Royal Marsden NHS Foundation Trust, London, United Kingdom., Nardozza F; IRCCS Regina Elena National Cancer Institute, UOSD Clinical Trial Center, Biostatistics and Bioinformatics, Rome, Italy., Neri E; Orthopaedic Oncology, Careggi University Hospital, Florence, Italy., Nilsson M; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Papakonstantinou A; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.; Department of Breast Cancer, Endocrine Tumors and Sarcoma, Karolinska Comprehensive Cancer Center, Karolinska University Hospital, Stockholm, Sweden., Pasquali S; Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Molecular Pharmacology Unit, Milan, Italy., Sbaraglia M; Department of Pathology, Azienda Ospedaliera di Padova, Padua, Italy., Scolari F; Orthopaedic Oncology, Careggi University Hospital, Florence, Italy., Szkandera J; Department of Internal Medicine, Division of Oncology, Medical University of Graz, Graz, Austria., Valverde C; Medical Oncology, Hospital Universitari Vall d'Hebron, Spain., Vincenzi B; Medical Oncology, Università Campus Bio-Medico, Rome, Italy., Vizzaccaro S; Istituto Oncologico Veneto IOV-IRCCS, Medical Oncology 1, Padua, Italy., Zuccheri F; IRCCS Istituto Ortopedico Rizzoli, Clinica Ortopedica e Traumatologica III a Prevalente Indirizzo Oncologico, Bologna, Italy., Stacchiotti S; Fondazione IRCCS Istituto Nazionale Tumori, Medical Oncology 2, Milan, Italy., Trama A; Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale Tumori, Evaluative Epidemiology Unit, Milan, Italy.
Source: PloS one [PLoS One] 2024 Aug 12; Vol. 19 (8), pp. e0308387. Date of Electronic Publication: 2024 Aug 12 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1932-6203
DOI:10.1371/journal.pone.0308387